Testing high-absorption antibiotics for short-bowel syndrome
Treatments studied
Part of Digestive system, Infections clinical trials.
This early (Phase 1) study tests how well certain antibiotics get absorbed in the body when you have short-bowel syndrome. It may help doctors choose antibiotics that work better through the mouth for people with this digestion problem.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have short-bowel syndrome
- You were recently treated for a confirmed infection using amoxicillin (with or without clavulanic acid), ofloxacin or levofloxacin, or sulfamethoxazole/trimethoprim
- You are currently a patient at the Hospital of Nancy’s Nutrition Support Unit or Infectious Disease Unit
- You have health coverage through the social security system
- You can have a physical exam and you have signed informed consent after being fully informed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if crofelemer can reduce diarrhea and fluid loss in people with short bowel syndrome who have a stoma (no colon connection) and need intravenous nutrition or fluids. The goal is to see if it improves gut function and quality of life.
This study tests a new treatment called FT1 for people with short bowel syndrome. It aims to help you absorb more nutrients and fluids from food, potentially reducing the need for IV nutrition.
This study looks at how bacteria in your gut help your digestive system adapt after short bowel surgery. Researchers will track your microbiota (the trillions of bacteria in your gut) to understand how it changes and helps your body adjust to having less small intestine.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
This trial tests whether adding a probiotic supplement to standard antibiotic therapy (rifaximin) works better than the antibiotic alone for treating small intestinal bacterial overgrowth (SIBO) in people with irritable bowel syndrome (IBS). If you have IBS and SIBO, this study could help find a more effective treatment.
This study compares three different antibiotics to treat small intestine bacterial overgrowth (an overgrowth of bacteria in the gut) in children in Bangladesh. It aims to find which antibiotic works best.
Hear when a new Short Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.